VHCP Management’s Ascendis Pharma A/S ASND Stock Holding History

VHCP Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.82M	Hold	90,000	–	–	1.96%	12
2016 Q3	$1.81M	Hold	90,000	–	–	1.78%	12
2016 Q2	$1.19M	Hold	90,000	–	–	1.24%	18
2016 Q1	$1.67M	Hold	90,000	–	–	1.45%	13
2015 Q4	$1.65M	Sell	90,000 -721,152	-89%	-$12.6M	1%	17
2015 Q3	$14.4M	Hold	811,152	–	–	3.68%	9
2015 Q2	$14.1M	Hold	811,152	–	–	3.97%	8
2015 Q1	$12.9M	Buy	+811,152	New	+$14.8M	2.97%	11

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

VHCP Management's ASND Position: Q4 2016 in Review

VHCP Management held its Ascendis Pharma A/S (ASND) position steady in Q4 2016 at 90,000 shares worth $1.82M. The position accounts for 1.96% of the portfolio, ranked #12.

VHCP Management first reported a position in ASND in Q1 2015 and has held it in 8 quarters since. The position peaked at $14.4M in Q3 2015. 31 funds tracked by Wall St. Rank hold ASND as of Q4 2016.

VHCP Management held 90,000 shares of Ascendis Pharma A/S worth $1.82M as of Q4 2016.
VHCP Management left its Ascendis Pharma A/S share count unchanged in Q4 2016.
Ascendis Pharma A/S made up 1.96% of VHCP Management's portfolio in Q4 2016, its #12 holding.
VHCP Management first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 8 quarters since.
VHCP Management's Ascendis Pharma A/S position peaked at $14.4M in Q3 2015.
31 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.